About Us
Shaping the future of autoimmune testing.
We’re a global market leader in autoimmune diagnostics, delivering highly accurate reagents and highly efficient automation to labs throughout the world.
News
disease areas
Accurate, non-invasive testing.
Accurate, non-invasive testing.
Inflammatory bowel disease (IBD) includes inflammatory conditions like Crohn’s disease and ulcerative colitis, that affect the colon and small intestine. If not properly diagnosed, complications such as intestinal obstructions and fistulas can arise. That’s why we offer the most comprehensive line of test options for IBD, including QUANTA Flash® Calprotectin, QUANTA Lite® Calprotectin Extended Range, and QUANTA Lite® ASCA IgG/IgA.
HIGHLIGHTS
- Patient care with comfort.Patients can be provided with insights on their condition with results from accurate, non-invasive testing.
- Confident labs improving patient care.Labs can feel confident that they are reporting highly accurate results.
- Helping clinicians every step of the way.Our tests help give clinicians insight into the differential diagnosis and disease activity for better patient management decisions.
Related Systems
QUANTA-Lyser® 4000
QUANTA-Lyser® 4000
High throughput IFA slide processor designed for the high-volume laboratory
QUANTA-Lyser® 3000
QUANTA-Lyser® 3000
QUANTA-Lyser 3000 is a high throughput EIA/IFA that give you the ability to complete your workload faster with less hands-on time.
QUANTA-Lyser® 160/240 EIA/IFA Processors
QUANTA-Lyser® 160/240 EIA/IFA Processors
Flexible EIA/IFA processing platform to meet the volume requirements of your laboratory
QUANTA-Lyser® 2
QUANTA-Lyser® 2
QUANTA-Lyser® 2 is the ideal platform for esoteric assays or in settings that require maximum flexibility and efficiency
BIO-FLASH®
BIO-FLASH®
Autoimmune chemiluminescent (CIA) analyzer eliminates batching and provides precise quantification.
NOVA View®
NOVA View®
Digital immunofluorescence assay (IFA) system with single well titer to increase the efficiency of your workflow.
